Kymera Therapeutics Inc (KYMR)
31.26
-2.03
(-6.10%)
USD |
NASDAQ |
Jun 17, 15:39
Kymera Therapeutics Total Liabilities (Quarterly): 157.05M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 157.05M |
| December 31, 2023 | 180.79M |
| September 30, 2023 | 156.84M |
| June 30, 2023 | 146.52M |
| March 31, 2023 | 151.90M |
| December 31, 2022 | 112.98M |
| September 30, 2022 | 125.59M |
| June 30, 2022 | 125.47M |
| March 31, 2022 | 134.34M |
| Date | Value |
|---|---|
| December 31, 2021 | 146.27M |
| September 30, 2021 | 159.32M |
| June 30, 2021 | 176.28M |
| March 31, 2021 | 189.30M |
| December 31, 2020 | 203.29M |
| September 30, 2020 | 212.68M |
| June 30, 2020 | 77.07M |
| December 31, 2019 | 191.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
77.07M
Minimum
Jun 2020
212.68M
Maximum
Sep 2020
155.69M
Average
156.84M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| SELLAS Life Sciences Group Inc | 14.75M |
| Iovance Biotherapeutics Inc | 189.81M |
| Immunic Inc | 20.58M |
| Protagonist Therapeutics Inc | 68.83M |
| Ovid Therapeutics Inc | 53.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 868.25M |
| Shareholders Equity (Quarterly) | 711.20M |
| Current Ratio | 9.571 |